Your browser doesn't support javascript.
loading
Percutaneous atrial shunt closure and the risk of recurrent ischemic stroke: A register-based, nationwide cohort study.
Karagianni, Alexia; Mandalenakis, Zacharias; Papadopoulos, Savvas; Dellborg, Mikael; Eriksson, Peter.
Afiliação
  • Karagianni A; Center for Adults with Congenital Heart Disease (ACHD), Sahlgrenska University Hospital/Östra, Sweden; Institute of Medicine, Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, Gothenburg University, Sweden. Electronic address: alexia.karagianni@vgregion.se.
  • Mandalenakis Z; Center for Adults with Congenital Heart Disease (ACHD), Sahlgrenska University Hospital/Östra, Sweden; Institute of Medicine, Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, Gothenburg University, Sweden. Electronic address: zacharias.mandalenakis@vgregion.se.
  • Papadopoulos S; Department of Business Administration, School of Business, Economics and Law, University of Gothenburg. Electronic address: savvas.papadopoulos@handels.gu.se.
  • Dellborg M; Center for Adults with Congenital Heart Disease (ACHD), Sahlgrenska University Hospital/Östra, Sweden; Institute of Medicine, Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, Gothenburg University, Sweden. Electronic address: mikael.dellborg@gu.se.
  • Eriksson P; Center for Adults with Congenital Heart Disease (ACHD), Sahlgrenska University Hospital/Östra, Sweden; Institute of Medicine, Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, Gothenburg University, Sweden. Electronic address: peter.eriksson@vgregion.se.
J Stroke Cerebrovasc Dis ; 32(6): 107084, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36965352
ABSTRACT

OBJECTIVES:

We aimed to investigate the risk of recurrent stroke in patients with transcatheter closure of an atrial shunt (ASCIos), compared to patients with an atrial shunt and cerebrovascular event (CVE) but only medical treated (ASMed), and to age- and sex-matched control individuals without a previous CVE.

METHODS:

In total, 663 ASCIos patients were identified in the Swedish National Patient Register from 1997 to 2016 and matched by using propensity score with 663 ASMed patients. Nine age- and sex-matched controls to ASCIos patients (n = 6,302) without a diagnosis of atrial shunt or history of CVE were randomly selected from the general population.

RESULTS:

At a mean follow-up of 6.5 years, the incidence rate of recurrent stroke in the ASCIos group vs ASMed group was 0.9 vs 0.7 per 100 patient-years. The hazard ratio of recurrent stroke in the ASCIos group compared with index stroke in the control group was 9.9 (95% confidence interval, 5.5-17.9). The incidence of atrial fibrillation was similar in the ASCIos and the ASMed group, however four times higher in the ASCIos than in the control group.

CONCLUSIONS:

Our large nationwide, register-based cohort study showed that, unexpectedly, the risk of recurrent stroke in the ASCos group was as high as in the ASMed group and almost ten times higher than the risk of an index stroke in matched controls without previous stroke.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Ataque Isquêmico Transitório / Acidente Vascular Cerebral / Forame Oval Patente / AVC Isquêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Ataque Isquêmico Transitório / Acidente Vascular Cerebral / Forame Oval Patente / AVC Isquêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article